My Story

The diagnosis confirmed what the tests showed: my immune system was producing antibodies that blocked acetylcholine receptors at the neuromuscular junction — the site where nerve signals trigger muscle contractions. Without those signals reaching the muscle, the muscle can't move.

The neurologist was direct. MG is a chronic autoimmune condition. It is managed, not cured. The standard of care is immunosuppression. I was told I would likely be on medication for the rest of my life. I heard it. I didn't accept it.

Prednisone quieted the immediate immune assault, providing enough stability to function day to day. I noticed only subtle improvement directly attributable to the medication — by the time symptoms were beginning to resolve, I had already been aggressively pursuing root-cause interventions in parallel.

I stepped away from work almost entirely during this period. Looking at screens worsened my double vision, and typing caused cramping and sudden muscle failure in my fingers. I began researching obsessively — in short sessions, using voice-to-text — into what was actually driving the immune dysregulation. The medication bought me time. I used every bit of it.

Parasites are far more prevalent in developed countries than mainstream medicine acknowledges. More importantly, they directly hijack immune regulation — suppressing certain immune responses while triggering others — in ways that can push an already burdened immune system into autoimmune behavior.

I completed a multi-week parasite cleanse protocol. What followed — both physically and in terms of symptom shifts — confirmed that parasitic burden had been a significant contributor to what was driving my immune dysregulation. This intervention, alongside the dietary changes and fasting, became one of the most important turning points of my recovery.

By early 2024, with strict dietary changes in place — eliminating seed oils, sugar, gluten, and processed foods — combined with daily intermittent fasting and the parasite protocol, my symptoms had improved by roughly 80%. I could see clearly again. Swallowing was no longer labored. I was returning to myself.

Within another 4-6 weeks, the remaining symptoms fully resolved. No eye drooping, no swallowing difficulty, no muscle weakness — about five months after my first symptom, I was symptom-free. AChR antibody levels were declining but would take much longer to fully normalize. This was the moment the root-cause approach proved itself — not through theory, but through measurable, sustained results.

Low Dose Naltrexone works by briefly blocking opioid receptors, which triggers a rebound increase in endorphins and helps regulate the immune system — an approach increasingly recognized for its benefits in autoimmune conditions.

LDN was added as a complement to the existing protocol. It was well tolerated with no notable side effects.

By the time CellCept was introduced, I was already largely symptom-free. I cannot speak to its direct effect on symptoms — I had addressed the root causes aggressively enough that my system was already stabilizing. I experienced zero notable side effects.

I view CellCept as a complementary layer — helping to calm the immune response while the deeper interventions continued to address what originally triggered it.

Tapering corticosteroids requires patience and close monitoring — reducing too quickly can allow suppressed immune activity to rebound. The taper was gradual and fully physician-supervised.

No rebound of symptoms occurred. The immune system was behaving itself — because the conditions that had triggered its dysregulation were no longer present.

AChR antibody levels continued to trend toward normal range. With consistent monitoring and no signs of disease recurrence, the team began reducing CellCept incrementally.

The goal is eventual medication independence — not because medications are the enemy, but because a genuinely healed immune system shouldn't require indefinite suppression.

My symptoms had already been gone for over two years by this point — but antibody levels and clinical markers take much longer to fully normalize than symptoms take to resolve. This was the point my neurologist could confirm, in the numbers, what I'd already been living: genuine clinical remission, not just managed suppression.

This is the outcome I was told was unlikely. It happened because I refused to accept symptom management as the ceiling of what was possible, and because I treated the root causes rather than only the symptoms they produced.

Even in remission, reducing the accumulated toxic burden in the body supports long-term immune stability. I completed a 90-day course of MasterPeace Zeolite — a binder that captures and removes heavy metals and environmental chemicals.

The process produced noticeable detox responses: vivid dreams and night sweats in week one, skin purging around month one, mild nausea near the end. All expected signs of the body actively clearing stored toxins.